28,143 Intuitive Surgical, Inc. $ISRG Shares Sold by Russell Investments Group Ltd.

Russell Investments Group Ltd. cut its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 506,154 shares of the medical equipment provider’s stock after selling 28,143 shares during the period. Russell Investments Group Ltd. owned approximately 0.15% of Intuitive Surgical worth $206,021,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in shares of Intuitive Surgical during the second quarter worth $14,316,000. Plato Investment Management Ltd bought a new stake in Intuitive Surgical in the 2nd quarter valued at $4,315,000. Hikari Power Ltd bought a new stake in Intuitive Surgical in the 2nd quarter valued at $5,619,000. NewEdge Advisors LLC boosted its stake in Intuitive Surgical by 19.1% in the 2nd quarter. NewEdge Advisors LLC now owns 50,825 shares of the medical equipment provider’s stock worth $20,212,000 after purchasing an additional 8,142 shares during the period. Finally, Concurrent Investment Advisors LLC boosted its stake in Intuitive Surgical by 30.8% in the 2nd quarter. Concurrent Investment Advisors LLC now owns 25,639 shares of the medical equipment provider’s stock worth $10,196,000 after purchasing an additional 6,043 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms have issued reports on ISRG. Citigroup lowered their target price on Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating for the company in a report on Friday, July 17th. Truist Financial reduced their price objective on Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating for the company in a research report on Thursday, July 16th. BMO Capital Markets reaffirmed an “outperform” rating on shares of Intuitive Surgical in a research report on Monday, July 20th. Zacks Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Thursday, October 22nd. Finally, Wells Fargo & Company reissued an “overweight” rating and issued a $486.00 target price (down from $487.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $493.54.

Intuitive Surgical Trading Down 2.1%

Intuitive Surgical stock opened at $439.89 on Friday. The company has a market cap of $152.48 billion, a P/E ratio of 53.19, a price-to-earnings-growth ratio of 3.10 and a beta of 1.45. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88. The company has a fifty day simple moving average of $416.12 and a 200 day simple moving average of $430.38.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The firm had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. During the same period in the previous year, the business earned $2.40 EPS. The company’s revenue was up 21.7% compared to the same quarter last year. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Insider Buying and Selling

In related news, VP Fredrik Widman sold 4,047 shares of the stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $453.21, for a total transaction of $1,834,140.87. Following the completion of the transaction, the vice president directly owned 1,026 shares of the company’s stock, valued at approximately $464,993.46. This represents a 79.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Craig H. Barratt sold 1,150 shares of the firm’s stock in a transaction that occurred on Friday, October 23rd. The shares were sold at an average price of $443.80, for a total value of $510,370.00. Following the completion of the transaction, the director owned 1,150 shares of the company’s stock, valued at approximately $510,370. This represents a 50.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 39,456 shares of company stock worth $17,769,124 over the last three months. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.